IA
AMRI

Icon Advisers’s Albany Molecular Research Inc AMRI Stock Holding History

Icon Advisers’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-30,300
Closed -$425K – 440
2017
Q1 		$425K Buy
+30,300
New +$496K 0.03% 350
2016
Q4 		– Sell
-52,000
Closed -$859K – 472
2016
Q3 		$859K Buy
+52,000
New +$770K 0.06% 318
2014
Q4 		– Sell
-16,600
Closed -$366K – 362
2014
Q3 		$366K Buy
+16,600
New +$340K 0.02% 305

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Icon Advisers's AMRI Position: Q2 2017 in Review

Icon Advisers sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 30,300 shares — an estimated $425K sold.

Icon Advisers first reported a position in AMRI in Q3 2014 and held it in 3 quarters. The position peaked at $859K in Q3 2016. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • Icon Advisers reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • Icon Advisers sold 30,300 Albany Molecular Research Inc shares in Q2 2017, an estimated $425K.
  • Icon Advisers first reported a position in Albany Molecular Research Inc in Q3 2014 and held it in 3 quarters.
  • Icon Advisers's Albany Molecular Research Inc position peaked at $859K in Q3 2016.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Icon Advisers's 13F filing for Q2 2017, filed 10 Aug 2017.